As expected, the APP levels quantified by TMT‐MS were significantly elevated in AD compared to controls and positively correlated with CERAD score, but there was no change observed in PSP (Figure 1E,F). The gene discussed is APP; the disease is supranuclear palsy, progressive, 1.